6 November 2023 - Women diagnosed with an aggressive form of breast cancer will have access to new treatment through the PBS.
Trastuzumab deruxtecan (Enhertu) will be listed on the PBS to treat patients who have been diagnosed with metastatic (stage IV) human epidermal growth factor receptor 2 positive breast cancer.